Esophageal Squamous Cell Carcinoma
Conditions
Interventions
During esophagogastroduodenoscopy for esophageal cancer screening and surveillance, participants will undergo iodine staining with 1.5% iodine solution.
During esophagogastroduodenoscopy for esophagea
Sponsors
Hokkaido University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Individuals who are predicted in advance to require iodine staining during esophagogastroduodenoscopy for esophageal cancer screening or surveillance, based on being at high risk for esophageal cancer Individuals who have received a full explanation of the study, fully understood its contents, and voluntarily agreed to participate by providing written informed consent
Exclusion criteria
Exclusion criteria: Individuals with an allergy to iodine Individuals diagnosed with advanced esophageal cancer (those with a history of esophageal cancer may be included if the cancer has been cured) Individuals with esophageal cancer of a histological type other than squamous cell carcinoma Individuals who are unable to undergo biopsy Individuals who have undergone iodine staining within the past month Individuals who have undergone surgery involving the esophagus Individuals who are deemed unsuitable for participation in the study by the principal investigator for any other reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic accuracy of 0.8% iodine staining compared to 1.5% iodine staining for superficial esophageal squamous cell carcinoma | — |
Countries
Japan
Contacts
Public ContactMasaki Inoue
Hokkaido University Hospital Division of Endoscopy
Outcome results
None listed